Centrexion acquires Boehringer pain compounds

Centrexion Therapeutics Corp. (Baltimore, Md.) acquired three pain compounds from Boehringer Ingelheim GmbH (Ingelheim, Germany) for undisclosed financial terms, adding to its pipeline of non-opioid, non-surgical pain programs.

Read the full 281 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE